Investor Stock List
Ranked #8,595 of 8,699 institutional investors

Lion Point Capital, LP

New York, NY

$14.6M
US stock portfolio at live prices · today −$177K (−1.20%)
Live prices, last trade 9:54 AM ET
Value at quarter end (Q3 2026)
$17.3M
Change from Q2 2026
−$3.6M (−17.43%)
Positions
27 · 0 new, 1 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$3.3M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
FENC 9.94%PRAX 9.38%MLTX 5.09%CMPS 4.47%IRON 4.19%
StockSharesValue, live% of portfoliovs Q2 2026
FENC Fennec Pharmaceuticals Inc.112,434$1.5M9.94%Unchanged
PRAX Praxis Precision Medicines, Inc.4,450$1.4M9.38%Unchanged
MLTX MoonLake Immunotherapeutics67,500$745K5.09%Unchanged
CMPS COMPASS Pathways plc80,000$653K4.47%Unchanged
IRON Disc Medicine, Inc.8,100$612K4.19%Unchanged
VTRS Viatris Inc.27,700$551K3.77%Unchanged
GERN Geron Corporation578,000$526K3.60%Unchanged
BNTC Benitec Biopharma Inc.62,000$490K3.36%Unchanged
AZTA Azenta, Inc.9,700$441K3.02%Unchanged
SRPT Sarepta Therapeutics, Inc.28,500$406K2.78%Unchanged
ARDX Ardelyx, Inc.128,650$390K2.67%Unchanged
BBIO BridgeBio Pharma, Inc.5,000$389K2.66%Unchanged
EWTX Edgewise Therapeutics, Inc.9,100$373K2.55%Unchanged
KURA Kura Oncology, Inc.46,000$336K2.30%Unchanged
SNDX Syndax Pharmaceuticals, Inc.36,000$328K2.24%Unchanged
MIST Milestone Pharmaceuticals Inc.820,000$321K2.20%Unchanged
HUMA Humacyte, Inc.650,000$320K2.19%Unchanged
DYN Dyne Therapeutics, Inc.18,000$292K2.00%Unchanged
CUE Cue Biopharma, Inc.52,928$251K1.71%Unchanged
JANX Janux Therapeutics, Inc.19,000$196K1.34%Unchanged
RGNX REGENXBIO Inc.26,600$190K1.30%Unchanged
RCKT Rocket Pharmaceuticals, Inc.86,000$182K1.25%Unchanged
INVA Innoviva, Inc.8,200$153K1.04%Unchanged
MLYS Mineralys Therapeutics, Inc.10,500$148K1.01%Unchanged
ARQT Arcutis Biotherapeutics, Inc.5,250$143K0.98%Unchanged
MCRB Seres Therapeutics, Inc.31,570$41K0.28%Unchanged
SPRB Spruce Biosciences, Inc.1,000$40K0.27%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
LNTH Lantheus Holdings, Inc.5,500$562K